1-Pentanoylamino-Cyclopentanecarboxylic Acid [2''-(1H-Tetrazol-5-Yl)-Biphenyl-4-Ylmethyl]-Amide
Get a Quick Quote Now
Select Packaging
Product Description
Product
1-Pentanoylamino-Cyclopentanecarboxylic Acid [2''-(1H-Tetrazol-5-Yl)-Biphenyl-4-Ylmethyl]-Amide
CAS
748812-53-5
Formula
C25H30N6O2
Synonym
1-(Pentanoylamino)-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)cyclopentanecarboxamide; 1-[(1-Oxopentyl)amino]-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]cyclopentanecarboxamide; AOBO-287 Irbesartan Related CoMpound A(1-pentanoyl...; Cyclopentanecarboxamide, 1-((1-oxopentyl)amino)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-; Irbesartan Impurity I(1-(pentanoylamino)-N-[[2-(1H-tetrazol -5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide); IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE); Irbesartan Related Compound A (25 mg) (1-pentanoylaminocyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide); Irbesartan Related CoMpound A(1-pentanoylaMino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylMethyl]-aMide); Irbesartan specified impurity A [EP]; N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentane-1-carboxamide; rbesartan EP IMp A (USP R C A); SR 49498; SR-49498; UNII-VC4PBS252C
Typical Product Specifications
SMILES
CCCCC(=O)NC1(CCCC1)C(=O)NCc2ccc(cc2)c3ccccc3c4[nH]nnn4
InChI
PAKGYCNZUGIDHV-UHFFFAOYSA-N
InChIKey
1S/C25H30N6O2/c1-2-3-10-22(32)27-25(15-6-7-16-25)24(33)26-17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-28-30-31-29-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,26,33)(H,27,32)(H,28,29,30,31)
Class
1-Pentanoylamino-Cyclopentanecarboxylic Acid [2''-(1H-Tetrazol-5-Yl)-Biphenyl-4-Ylmethyl]-Amide
Product Description
Product
1-Pentanoylamino-Cyclopentanecarboxylic Acid [2''-(1H-Tetrazol-5-Yl)-Biphenyl-4-Ylmethyl]-Amide
CAS
748812-53-5
Formula
C25H30N6O2
Synonym
1-(Pentanoylamino)-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)cyclopentanecarboxamide; 1-[(1-Oxopentyl)amino]-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]cyclopentanecarboxamide; AOBO-287 Irbesartan Related CoMpound A(1-pentanoyl...; Cyclopentanecarboxamide, 1-((1-oxopentyl)amino)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-; Irbesartan Impurity I(1-(pentanoylamino)-N-[[2-(1H-tetrazol -5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide); IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE); Irbesartan Related Compound A (25 mg) (1-pentanoylaminocyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide); Irbesartan Related CoMpound A(1-pentanoylaMino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylMethyl]-aMide); Irbesartan specified impurity A [EP]; N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentane-1-carboxamide; rbesartan EP IMp A (USP R C A); SR 49498; SR-49498; UNII-VC4PBS252C
Typical Product Specifications
SMILES
CCCCC(=O)NC1(CCCC1)C(=O)NCc2ccc(cc2)c3ccccc3c4[nH]nnn4
InChI
PAKGYCNZUGIDHV-UHFFFAOYSA-N
InChIKey
1S/C25H30N6O2/c1-2-3-10-22(32)27-25(15-6-7-16-25)24(33)26-17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-28-30-31-29-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,26,33)(H,27,32)(H,28,29,30,31)
Class
